Dr. Richard Glickman resigned as Chairman of the Board of Directors, effective July 15, 2026. Michael Heffernan, a current Board member, has been appointed as the new Chairman of the Board. enGene Therapeutics Inc. is a clinical-stage biotechnology company developing non-viral genetic medicines.
